カテゴリ： 世界, 医療/バイオ, QYResearch

ペット用抗炎症薬の世界市場2023年：粉末状、液体状

■ 英語タイトル：Global Anti-inflammatory Medicine for Pets Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8674）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8674
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ペット用抗炎症薬の世界市場2023年：粉末状、液体状]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はペット用抗炎症薬のグローバル市場について調査・分析し、世界のペット用抗炎症薬市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（粉末状、液体状）、用途別セグメント分析（猫、犬、爬虫類、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Zoetis、Boehringer Ingelheim、Merck、Elanco、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Ouro Fino Saude、Norbrook、Jindun、Wuhan chopperlvya、CAHICなどが含まれています。ペット用抗炎症薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ペット用抗炎症薬市場規模を算出する際に考慮しました。

・ペット用抗炎症薬市場の概要
- 製品の定義
- ペット用抗炎症薬の種類別セグメント
- 世界のペット用抗炎症薬市場規模：タイプ別分析（粉末状、液体状）
- ペット用抗炎症薬の用途別セグメント
- 世界のペット用抗炎症薬市場規模：用途別分析（猫、犬、爬虫類、その他）
- 世界のペット用抗炎症薬市場規模予測（2018年-2029年）
- ペット用抗炎症薬の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ペット用抗炎症薬市場の競争状況およびトレンド

・ペット用抗炎症薬の地域別市場規模
- 北米のペット用抗炎症薬市場規模（2018年-2029年）
- 米国のペット用抗炎症薬市場規模（2018年-2029年）
- ヨーロッパのペット用抗炎症薬市場規模（2018年-2029年）
- アジア太平洋のペット用抗炎症薬市場規模（2018年-2029年）
- 中国のペット用抗炎症薬市場規模（2018年-2029年）
- 日本のペット用抗炎症薬市場規模（2018年-2029年）
- 韓国のペット用抗炎症薬市場規模（2018年-2029年）
- インドのペット用抗炎症薬市場規模（2018年-2029年）
- オーストラリアのペット用抗炎症薬市場規模（2018年-2029年）
- 中南米のペット用抗炎症薬市場規模（2018年-2029年）
- 中東・アフリカのペット用抗炎症薬市場規模（2018年-2029年）

・種類別セグメント：粉末状、液体状
- 世界のペット用抗炎症薬のタイプ別販売量（2018年-2023年）
- 世界のペット用抗炎症薬のタイプ別売上（2018年-2023年）
- 世界のペット用抗炎症薬のタイプ別価格

・用途別セグメント：猫、犬、爬虫類、その他
- 世界のペット用抗炎症薬の用途別販売量（2018年-2023年）
- 世界のペット用抗炎症薬の用途別売上（2018年-2023年）
- 世界のペット用抗炎症薬の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Zoetis、Boehringer Ingelheim、Merck、Elanco、Virbac、Dechra Veterinary Products、Ceva、Vetoquinol、Ouro Fino Saude、Norbrook、Jindun、Wuhan chopperlvya、CAHIC

・産業チェーンと販売チャネルの分析
- ペット用抗炎症薬産業チェーン分析
- ペット用抗炎症薬の主要原材料
- ペット用抗炎症薬の販売チャネル
- ペット用抗炎症薬のディストリビューター
- ペット用抗炎症薬の主要顧客

・ペット用抗炎症薬市場ダイナミクス
- ペット用抗炎症薬の業界動向
- ペット用抗炎症薬市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Pet medicine refers to medicines administered to pets. In terms of purpose of use, dogs and cats are the main users of pet medicines. Drugs are used to prevent and treat pet diseases, improve the cure rate of pet diseases, and ensure the physical and mental health of pets.
Highlights
The global Anti-inflammatory Medicine for Pets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Anti-inflammatory Medicine for Pets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Anti-inflammatory Medicine for Pets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Anti-inflammatory Medicine for Pets include Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol and Ouro Fino Saude, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Medicine for Pets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Medicine for Pets.
The Anti-inflammatory Medicine for Pets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Anti-inflammatory Medicine for Pets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Medicine for Pets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Wuhan chopperlvya
CAHIC
Segment by Type
Powder
Liquid
Segment by Application
Cat
Dog
Reptile
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-inflammatory Medicine for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-inflammatory Medicine for Pets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Anti-inflammatory Medicine for Pets Market Overview
1.1 Product Overview and Scope of Anti-inflammatory Medicine for Pets
1.2 Anti-inflammatory Medicine for Pets Segment by Type
1.2.1 Global Anti-inflammatory Medicine for Pets Market Value Comparison by Type (2023-2029)
1.2.2 Powder
1.2.3 Liquid
1.3 Anti-inflammatory Medicine for Pets Segment by Application
1.3.1 Global Anti-inflammatory Medicine for Pets Market Value by Application: (2023-2029)
1.3.2 Cat
1.3.3 Dog
1.3.4 Reptile
1.3.5 Other
1.4 Global Anti-inflammatory Medicine for Pets Market Size Estimates and Forecasts
1.4.1 Global Anti-inflammatory Medicine for Pets Revenue 2018-2029
1.4.2 Global Anti-inflammatory Medicine for Pets Sales 2018-2029
1.4.3 Global Anti-inflammatory Medicine for Pets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti-inflammatory Medicine for Pets Market Competition by Manufacturers
2.1 Global Anti-inflammatory Medicine for Pets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-inflammatory Medicine for Pets Average Price by Manufacturers (2018-2023)
2.4 Global Anti-inflammatory Medicine for Pets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Product Type & Application
2.7 Anti-inflammatory Medicine for Pets Market Competitive Situation and Trends
2.7.1 Anti-inflammatory Medicine for Pets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-inflammatory Medicine for Pets Players Market Share by Revenue
2.7.3 Global Anti-inflammatory Medicine for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-inflammatory Medicine for Pets Retrospective Market Scenario by Region
3.1 Global Anti-inflammatory Medicine for Pets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti-inflammatory Medicine for Pets Global Anti-inflammatory Medicine for Pets Sales by Region: 2018-2029
3.2.1 Global Anti-inflammatory Medicine for Pets Sales by Region: 2018-2023
3.2.2 Global Anti-inflammatory Medicine for Pets Sales by Region: 2024-2029
3.3 Global Anti-inflammatory Medicine for Pets Global Anti-inflammatory Medicine for Pets Revenue by Region: 2018-2029
3.3.1 Global Anti-inflammatory Medicine for Pets Revenue by Region: 2018-2023
3.3.2 Global Anti-inflammatory Medicine for Pets Revenue by Region: 2024-2029
3.4 North America Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.4.1 North America Anti-inflammatory Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti-inflammatory Medicine for Pets Sales by Country (2018-2029)
3.4.3 North America Anti-inflammatory Medicine for Pets Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.5.1 Europe Anti-inflammatory Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti-inflammatory Medicine for Pets Sales by Country (2018-2029)
3.5.3 Europe Anti-inflammatory Medicine for Pets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-inflammatory Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti-inflammatory Medicine for Pets Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti-inflammatory Medicine for Pets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.7.1 Latin America Anti-inflammatory Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti-inflammatory Medicine for Pets Sales by Country (2018-2029)
3.7.3 Latin America Anti-inflammatory Medicine for Pets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-inflammatory Medicine for Pets Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-inflammatory Medicine for Pets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti-inflammatory Medicine for Pets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti-inflammatory Medicine for Pets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-inflammatory Medicine for Pets Sales by Type (2018-2029)
4.1.1 Global Anti-inflammatory Medicine for Pets Sales by Type (2018-2023)
4.1.2 Global Anti-inflammatory Medicine for Pets Sales by Type (2024-2029)
4.1.3 Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2018-2029)
4.2 Global Anti-inflammatory Medicine for Pets Revenue by Type (2018-2029)
4.2.1 Global Anti-inflammatory Medicine for Pets Revenue by Type (2018-2023)
4.2.2 Global Anti-inflammatory Medicine for Pets Revenue by Type (2024-2029)
4.2.3 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2018-2029)
4.3 Global Anti-inflammatory Medicine for Pets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti-inflammatory Medicine for Pets Sales by Application (2018-2029)
5.1.1 Global Anti-inflammatory Medicine for Pets Sales by Application (2018-2023)
5.1.2 Global Anti-inflammatory Medicine for Pets Sales by Application (2024-2029)
5.1.3 Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2018-2029)
5.2 Global Anti-inflammatory Medicine for Pets Revenue by Application (2018-2029)
5.2.1 Global Anti-inflammatory Medicine for Pets Revenue by Application (2018-2023)
5.2.2 Global Anti-inflammatory Medicine for Pets Revenue by Application (2024-2029)
5.2.3 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2018-2029)
5.3 Global Anti-inflammatory Medicine for Pets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Zoetis Anti-inflammatory Medicine for Pets Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Merck Anti-inflammatory Medicine for Pets Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Elanco Anti-inflammatory Medicine for Pets Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Virbac Anti-inflammatory Medicine for Pets Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Dechra Veterinary Products
6.6.1 Dechra Veterinary Products Corporation Information
6.6.2 Dechra Veterinary Products Description and Business Overview
6.6.3 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Product Portfolio
6.6.5 Dechra Veterinary Products Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ceva Anti-inflammatory Medicine for Pets Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Vetoquinol Anti-inflammatory Medicine for Pets Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Ouro Fino Saude
6.9.1 Ouro Fino Saude Corporation Information
6.9.2 Ouro Fino Saude Description and Business Overview
6.9.3 Ouro Fino Saude Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Ouro Fino Saude Anti-inflammatory Medicine for Pets Product Portfolio
6.9.5 Ouro Fino Saude Recent Developments/Updates
6.10 Norbrook
6.10.1 Norbrook Corporation Information
6.10.2 Norbrook Description and Business Overview
6.10.3 Norbrook Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Norbrook Anti-inflammatory Medicine for Pets Product Portfolio
6.10.5 Norbrook Recent Developments/Updates
6.11 Jindun
6.11.1 Jindun Corporation Information
6.11.2 Jindun Anti-inflammatory Medicine for Pets Description and Business Overview
6.11.3 Jindun Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Jindun Anti-inflammatory Medicine for Pets Product Portfolio
6.11.5 Jindun Recent Developments/Updates
6.12 Wuhan chopperlvya
6.12.1 Wuhan chopperlvya Corporation Information
6.12.2 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Description and Business Overview
6.12.3 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Product Portfolio
6.12.5 Wuhan chopperlvya Recent Developments/Updates
6.13 CAHIC
6.13.1 CAHIC Corporation Information
6.13.2 CAHIC Anti-inflammatory Medicine for Pets Description and Business Overview
6.13.3 CAHIC Anti-inflammatory Medicine for Pets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 CAHIC Anti-inflammatory Medicine for Pets Product Portfolio
6.13.5 CAHIC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-inflammatory Medicine for Pets Industry Chain Analysis
7.2 Anti-inflammatory Medicine for Pets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-inflammatory Medicine for Pets Production Mode & Process
7.4 Anti-inflammatory Medicine for Pets Sales and Marketing
7.4.1 Anti-inflammatory Medicine for Pets Sales Channels
7.4.2 Anti-inflammatory Medicine for Pets Distributors
7.5 Anti-inflammatory Medicine for Pets Customers
8 Anti-inflammatory Medicine for Pets Market Dynamics
8.1 Anti-inflammatory Medicine for Pets Industry Trends
8.2 Anti-inflammatory Medicine for Pets Market Drivers
8.3 Anti-inflammatory Medicine for Pets Market Challenges
8.4 Anti-inflammatory Medicine for Pets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Anti-inflammatory Medicine for Pets Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Anti-inflammatory Medicine for Pets Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Anti-inflammatory Medicine for Pets Market Competitive Situation by Manufacturers in 2022
Table 4. Global Anti-inflammatory Medicine for Pets Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Anti-inflammatory Medicine for Pets Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Anti-inflammatory Medicine for Pets Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Anti-inflammatory Medicine for Pets Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Anti-inflammatory Medicine for Pets Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Anti-inflammatory Medicine for Pets, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Product Type & Application
Table 12. Global Key Manufacturers of Anti-inflammatory Medicine for Pets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-inflammatory Medicine for Pets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Medicine for Pets as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-inflammatory Medicine for Pets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Anti-inflammatory Medicine for Pets Sales by Region (2018-2023) & (K Units)
Table 18. Global Anti-inflammatory Medicine for Pets Sales Market Share by Region (2018-2023)
Table 19. Global Anti-inflammatory Medicine for Pets Sales by Region (2024-2029) & (K Units)
Table 20. Global Anti-inflammatory Medicine for Pets Sales Market Share by Region (2024-2029)
Table 21. Global Anti-inflammatory Medicine for Pets Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2018-2023)
Table 23. Global Anti-inflammatory Medicine for Pets Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2024-2029)
Table 25. North America Anti-inflammatory Medicine for Pets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Anti-inflammatory Medicine for Pets Sales by Country (2018-2023) & (K Units)
Table 27. North America Anti-inflammatory Medicine for Pets Sales by Country (2024-2029) & (K Units)
Table 28. North America Anti-inflammatory Medicine for Pets Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Anti-inflammatory Medicine for Pets Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Anti-inflammatory Medicine for Pets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Anti-inflammatory Medicine for Pets Sales by Country (2018-2023) & (K Units)
Table 32. Europe Anti-inflammatory Medicine for Pets Sales by Country (2024-2029) & (K Units)
Table 33. Europe Anti-inflammatory Medicine for Pets Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Anti-inflammatory Medicine for Pets Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Anti-inflammatory Medicine for Pets Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Anti-inflammatory Medicine for Pets Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Anti-inflammatory Medicine for Pets Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Anti-inflammatory Medicine for Pets Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Anti-inflammatory Medicine for Pets Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Anti-inflammatory Medicine for Pets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Anti-inflammatory Medicine for Pets Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Anti-inflammatory Medicine for Pets Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Anti-inflammatory Medicine for Pets Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Anti-inflammatory Medicine for Pets Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Anti-inflammatory Medicine for Pets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Anti-inflammatory Medicine for Pets Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Anti-inflammatory Medicine for Pets Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Anti-inflammatory Medicine for Pets Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Anti-inflammatory Medicine for Pets Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Anti-inflammatory Medicine for Pets Sales (K Units) by Type (2018-2023)
Table 51. Global Anti-inflammatory Medicine for Pets Sales (K Units) by Type (2024-2029)
Table 52. Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2018-2023)
Table 53. Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2024-2029)
Table 54. Global Anti-inflammatory Medicine for Pets Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Anti-inflammatory Medicine for Pets Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2018-2023)
Table 57. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2024-2029)
Table 58. Global Anti-inflammatory Medicine for Pets Price (US$/Unit) by Type (2018-2023)
Table 59. Global Anti-inflammatory Medicine for Pets Price (US$/Unit) by Type (2024-2029)
Table 60. Global Anti-inflammatory Medicine for Pets Sales (K Units) by Application (2018-2023)
Table 61. Global Anti-inflammatory Medicine for Pets Sales (K Units) by Application (2024-2029)
Table 62. Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2018-2023)
Table 63. Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2024-2029)
Table 64. Global Anti-inflammatory Medicine for Pets Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Anti-inflammatory Medicine for Pets Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2018-2023)
Table 67. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2024-2029)
Table 68. Global Anti-inflammatory Medicine for Pets Price (US$/Unit) by Application (2018-2023)
Table 69. Global Anti-inflammatory Medicine for Pets Price (US$/Unit) by Application (2024-2029)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Zoetis Anti-inflammatory Medicine for Pets Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Boehringer Ingelheim Anti-inflammatory Medicine for Pets Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Merck Anti-inflammatory Medicine for Pets Product
Table 84. Merck Recent Developments/Updates
Table 85. Elanco Corporation Information
Table 86. Elanco Description and Business Overview
Table 87. Elanco Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Elanco Anti-inflammatory Medicine for Pets Product
Table 89. Elanco Recent Developments/Updates
Table 90. Virbac Corporation Information
Table 91. Virbac Description and Business Overview
Table 92. Virbac Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Virbac Anti-inflammatory Medicine for Pets Product
Table 94. Virbac Recent Developments/Updates
Table 95. Dechra Veterinary Products Corporation Information
Table 96. Dechra Veterinary Products Description and Business Overview
Table 97. Dechra Veterinary Products Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Dechra Veterinary Products Anti-inflammatory Medicine for Pets Product
Table 99. Dechra Veterinary Products Recent Developments/Updates
Table 100. Ceva Corporation Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Ceva Anti-inflammatory Medicine for Pets Product
Table 104. Ceva Recent Developments/Updates
Table 105. Vetoquinol Corporation Information
Table 106. Vetoquinol Description and Business Overview
Table 107. Vetoquinol Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Vetoquinol Anti-inflammatory Medicine for Pets Product
Table 109. Vetoquinol Recent Developments/Updates
Table 110. Ouro Fino Saude Corporation Information
Table 111. Ouro Fino Saude Description and Business Overview
Table 112. Ouro Fino Saude Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Ouro Fino Saude Anti-inflammatory Medicine for Pets Product
Table 114. Ouro Fino Saude Recent Developments/Updates
Table 115. Norbrook Corporation Information
Table 116. Norbrook Description and Business Overview
Table 117. Norbrook Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Norbrook Anti-inflammatory Medicine for Pets Product
Table 119. Norbrook Recent Developments/Updates
Table 120. Jindun Corporation Information
Table 121. Jindun Description and Business Overview
Table 122. Jindun Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Jindun Anti-inflammatory Medicine for Pets Product
Table 124. Jindun Recent Developments/Updates
Table 125. Wuhan chopperlvya Corporation Information
Table 126. Wuhan chopperlvya Description and Business Overview
Table 127. Wuhan chopperlvya Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Wuhan chopperlvya Anti-inflammatory Medicine for Pets Product
Table 129. Wuhan chopperlvya Recent Developments/Updates
Table 130. CAHIC Corporation Information
Table 131. CAHIC Description and Business Overview
Table 132. CAHIC Anti-inflammatory Medicine for Pets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. CAHIC Anti-inflammatory Medicine for Pets Product
Table 134. CAHIC Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Anti-inflammatory Medicine for Pets Distributors List
Table 138. Anti-inflammatory Medicine for Pets Customers List
Table 139. Anti-inflammatory Medicine for Pets Market Trends
Table 140. Anti-inflammatory Medicine for Pets Market Drivers
Table 141. Anti-inflammatory Medicine for Pets Market Challenges
Table 142. Anti-inflammatory Medicine for Pets Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-inflammatory Medicine for Pets
Figure 2. Global Anti-inflammatory Medicine for Pets Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Anti-inflammatory Medicine for Pets Market Share by Type in 2022 & 2029
Figure 4. Powder Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Anti-inflammatory Medicine for Pets Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Anti-inflammatory Medicine for Pets Market Share by Application in 2022 & 2029
Figure 8. Cat
Figure 9. Dog
Figure 10. Reptile
Figure 11. Other
Figure 12. Global Anti-inflammatory Medicine for Pets Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Anti-inflammatory Medicine for Pets Market Size (2018-2029) & (US$ Million)
Figure 14. Global Anti-inflammatory Medicine for Pets Sales (2018-2029) & (K Units)
Figure 15. Global Anti-inflammatory Medicine for Pets Average Price (US$/Unit) & (2018-2029)
Figure 16. Anti-inflammatory Medicine for Pets Report Years Considered
Figure 17. Anti-inflammatory Medicine for Pets Sales Share by Manufacturers in 2022
Figure 18. Global Anti-inflammatory Medicine for Pets Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Anti-inflammatory Medicine for Pets Players: Market Share by Revenue in 2022
Figure 20. Anti-inflammatory Medicine for Pets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Anti-inflammatory Medicine for Pets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Anti-inflammatory Medicine for Pets Sales Market Share by Country (2018-2029)
Figure 23. North America Anti-inflammatory Medicine for Pets Revenue Market Share by Country (2018-2029)
Figure 24. United States Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Anti-inflammatory Medicine for Pets Sales Market Share by Country (2018-2029)
Figure 27. Europe Anti-inflammatory Medicine for Pets Revenue Market Share by Country (2018-2029)
Figure 28. Germany Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Anti-inflammatory Medicine for Pets Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2018-2029)
Figure 35. China Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Anti-inflammatory Medicine for Pets Sales Market Share by Country (2018-2029)
Figure 45. Latin America Anti-inflammatory Medicine for Pets Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Colombia Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Anti-inflammatory Medicine for Pets Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Anti-inflammatory Medicine for Pets Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Anti-inflammatory Medicine for Pets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Anti-inflammatory Medicine for Pets by Type (2018-2029)
Figure 56. Global Revenue Market Share of Anti-inflammatory Medicine for Pets by Type (2018-2029)
Figure 57. Global Anti-inflammatory Medicine for Pets Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Anti-inflammatory Medicine for Pets by Application (2018-2029)
Figure 59. Global Revenue Market Share of Anti-inflammatory Medicine for Pets by Application (2018-2029)
Figure 60. Global Anti-inflammatory Medicine for Pets Price (US$/Unit) by Application (2018-2029)
Figure 61. Anti-inflammatory Medicine for Pets Value Chain
Figure 62. Anti-inflammatory Medicine for Pets Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ペット用体外駆虫薬のグローバル市場展望 2023年-2029年：液体、粉末、錠剤、その他
  • 癒着防止ジェルの世界市場2023年：注入式、塗抹式
  • いびき防止歯科用装置の世界市場2023年：下顎前進装置（MAD）、舌保持装置（TRD）
  • PET核医学映像検査の世界市場2023年：PET-CT、PET-MRI、その他
  • 即効性喘息治療薬の世界市場2023年：錠剤、スプレー
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8674 )"ペット用抗炎症薬の世界市場2023年：粉末状、液体状" (英文：Global Anti-inflammatory Medicine for Pets Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。